Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Filings indexed 992 across all filing types
Latest filing 2022-08-22 Board/Management Inform…
Country FI Finland
Listing HE BIOBV

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
08224190.pdf
Board/Management Information Classification · 100% confidence The document is a short announcement regarding a change in the company's management team (specifically the appointment of a new member to the leadership team). It fits the definition of a board/management information announcement.
2022-08-22 Finnish
Muutoksia Biohit Oyj:n johtoryhmässä
Board/Management Information Classification · 100% confidence The document is a short announcement titled 'Muutoksia Biohit Oyj:n johtoryhmässä' (Changes in Biohit Oyj's management team). It details the appointment of a new member to the management team, Panu Hendolin, effective September 1, 2022. This falls directly under the definition of a management/board change announcement.
2022-08-22 Finnish
Muutoksia Biohit Oyj:n johtoryhmässä
Board/Management Information Classification · 99% confidence The document is titled 'Muutoksia Biohit Oyj:n johtoryhmässä' (Changes in the Management Team of Biohit Oyj) and announces the appointment of Panu Hendolin to the management team starting September 1, 2022. This directly relates to changes in senior management personnel. According to the definitions, 'Board/Management Information' (Code: MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' The document is short and contains the announcement itself, not a link to a larger report, confirming it is the primary announcement type.
2022-08-22 Finnish
Changes to Biohit Oyj's management
Board/Management Information Classification · 99% confidence The document explicitly announces a change in the company's management team, specifically the appointment of Panu Hendolin, PhD, as a member of the Management Team, effective September 1, 2022. This directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2022-08-22 English
08087951.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj for the period of January-June 2022. It contains comprehensive financial statements, key performance indicators, management commentary, and outlook for the period. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-10 Finnish
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj for the period ending June 30, 2022. It contains comprehensive financial statements, key performance indicators (KPIs), management discussion and analysis (MDA), and operational updates. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis for a period shorter than a full fiscal year. H1 2022
2022-08-10 Finnish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.